BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26421697)

  • 1. Whole-blood neutrophil gelatinase-associated lipocalin to predict adverse events in acute kidney injury: A prospective observational cohort study.
    Rewa O; Wald R; Adhikari NK; Hladunewich M; Lapinsky S; Muscedere J; Bagshaw SM; Smith OM; Lebovic G; Kuint R; Klein DJ
    J Crit Care; 2015 Dec; 30(6):1359-64. PubMed ID: 26421697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.
    Ricci Z; Netto R; Garisto C; Iacoella C; Favia I; Cogo P
    Pediatr Crit Care Med; 2012 Nov; 13(6):667-70. PubMed ID: 22895007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neutrophil gelatinase-associated lipocalin and adverse outcome in critically ill patients with ventilatory support.
    Linko R; Pettilä V; Kuitunen A; Korhonen AM; Nisula S; Alila S; Kiviniemi O; Laru-Sompa R; Varpula T; Karlsson S;
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):855-62. PubMed ID: 23556459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
    Kümpers P; Hafer C; Lukasz A; Lichtinghagen R; Brand K; Fliser D; Faulhaber-Walter R; Kielstein JT
    Crit Care; 2010; 14(1):R9. PubMed ID: 20122150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy.
    Tiranathanagul K; Amornsuntorn S; Avihingsanon Y; Srisawat N; Susantitaphong P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Ther Apher Dial; 2013 Jun; 17(3):332-8. PubMed ID: 23735150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
    Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.
    de Geus HR; Bakker J; Lesaffre EM; le Noble JL
    Am J Respir Crit Care Med; 2011 Apr; 183(7):907-14. PubMed ID: 20935115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.
    Zarbock A; Kellum JA; Schmidt C; Van Aken H; Wempe C; Pavenstädt H; Boanta A; Gerß J; Meersch M
    JAMA; 2016 May 24-31; 315(20):2190-9. PubMed ID: 27209269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts acute kidney injury in septic shock at ICU admission].
    Camou F; Oger S; Paroissin C; Guilhon E; Guisset O; Mourissoux G; Pouyes H; Lalanne T; Gabinski C
    Ann Fr Anesth Reanim; 2013 Mar; 32(3):157-64. PubMed ID: 23453486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study.
    Constantin JM; Futier E; Perbet S; Roszyk L; Lautrette A; Gillart T; Guerin R; Jabaudon M; Souweine B; Bazin JE; Sapin V
    J Crit Care; 2010 Mar; 25(1):176.e1-6. PubMed ID: 19781900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neutrophil gelatinase-associated lipocalin as early biomarker for acute kidney injury in burn patients.
    Hong DY; Lee JH; Park SO; Baek KJ; Lee KR
    J Burn Care Res; 2013; 34(6):e326-32. PubMed ID: 23511281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis.
    Hjortrup PB; Haase N; Treschow F; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2015 Jan; 59(1):25-34. PubMed ID: 25363361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
    Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
    Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.
    Haase M; Devarajan P; Haase-Fielitz A; Bellomo R; Cruz DN; Wagener G; Krawczeski CD; Koyner JL; Murray P; Zappitelli M; Goldstein SL; Makris K; Ronco C; Martensson J; Martling CR; Venge P; Siew E; Ware LB; Ikizler TA; Mertens PR
    J Am Coll Cardiol; 2011 Apr; 57(17):1752-61. PubMed ID: 21511111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge.
    Ito M; Doi K; Takahashi M; Koyama K; Myojo M; Hosoya Y; Kiyosue A; Ando J; Noiri E; Yahagi N; Hirata Y; Komuro I
    J Cardiol; 2016 Feb; 67(2):184-91. PubMed ID: 26228001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis.
    Shapiro NI; Trzeciak S; Hollander JE; Birkhahn R; Otero R; Osborn TM; Moretti E; Nguyen HB; Gunnerson K; Milzman D; Gaieski DF; Goyal M; Cairns CB; Kupfer K; Lee SW; Rivers EP
    Ann Emerg Med; 2010 Jul; 56(1):52-59.e1. PubMed ID: 20363526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
    Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of plasma neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care unit patients after major non-cardiac surgery.
    Shum HP; Leung NY; Chang LL; Tam OY; Kwan AM; Chan KC; Yan WW; Chan TM
    Nephrology (Carlton); 2015 May; 20(5):375-82. PubMed ID: 25605005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.